136774-74-8

Basic information

• Product Name: (3-AMino-2-chlorophenyl)Methanol
• Synonyms: (3-AMino-2-chlorophenyl)Methanol
• CAS NO: 136774-74-8
• Molecular Formula: C₇H₈ClNO
• Molecular Weight: 157.59752
• Mol File: 136774-74-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (3-AMino-2-chlorophenyl)Methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (3-AMino-2-chlorophenyl)Methanol(136774-74-8)
• EPA Substance Registry System: (3-AMino-2-chlorophenyl)Methanol(136774-74-8)

Safety Data

• Hazardous Substances Data: 136774-74-8(Hazardous Substances Data)

Usage

General Description

(3-Amino-2-chlorophenyl)Methanol is a chemical compound with the molecular formula C7H8ClNO, which consists of a benzene ring with an amino group and a hydroxyl group attached to it. It is commonly used as a building block in the synthesis of various pharmaceuticals and agrochemicals. The compound has been studied for its potential pharmacological activities, including anti-cancer and anti-inflammatory properties. It is also used as an intermediate in the production of dyes and other organic compounds. Additionally, (3-Amino-2-chlorophenyl)Methanol is known to exhibit analgesic and sedative properties, making it a versatile compound with a range of potential applications in the chemical and pharmaceutical industries.

Downstream Products

• 1071927-78-0 N-(3-(5-(3,5-dichlorophenyl)-4,5-dihydro-5-trifluoromethyl-isoxazol-3-yl)-2-chloro-phenyl)-3,3,3-trifluoro-propanamide 
• 1071927-95-1 2-chloro-3-((3,3,3-trifluoro-propionyl)amino)-benzaldehyde 
• 1071927-94-0 3-amino-2-chloro-benzaldehyde 

Relevant articles and documents

BIPHENYL-4-YL-SULFONIC ACID ARYLAMIDES AND THEIR USE AS THERAPEUTIC AGENTS

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl sulfonamides and related compounds (collectively referred to herein as "BPSAAA compounds"), as described herein, and including, for example, biphenyl-4-sulfonic acid (hydroxyalkyl-phenyl)-amides and related compounds. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment and/or prevention, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of, inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activation in rheumatoid arthritis, osteoporosis, cancer associated bone disease, Paget's disease and the like.